[go: up one dir, main page]

NO20084914L - Parenteral formulering inneholdende proton pumpeinhibitor sterilisert i dens siste beholder ved ioniserende straling - Google Patents

Parenteral formulering inneholdende proton pumpeinhibitor sterilisert i dens siste beholder ved ioniserende straling

Info

Publication number
NO20084914L
NO20084914L NO20084914A NO20084914A NO20084914L NO 20084914 L NO20084914 L NO 20084914L NO 20084914 A NO20084914 A NO 20084914A NO 20084914 A NO20084914 A NO 20084914A NO 20084914 L NO20084914 L NO 20084914L
Authority
NO
Norway
Prior art keywords
sterilized
formulation
proton pump
pump inhibitor
parenteral formulation
Prior art date
Application number
NO20084914A
Other languages
English (en)
Norwegian (no)
Inventor
Mikael Bruells
Johanna Karlsson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20084914L publication Critical patent/NO20084914L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0029—Radiation
    • A61L2/0035—Gamma radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20084914A 2006-05-09 2008-11-21 Parenteral formulering inneholdende proton pumpeinhibitor sterilisert i dens siste beholder ved ioniserende straling NO20084914L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79905806P 2006-05-09 2006-05-09
PCT/SE2007/000440 WO2007129961A1 (fr) 2006-05-09 2007-05-07 Formulation parentérale comprenant un inhibiteur de la pompe à protons stérilisé dans son récipient final par un rayonnement ionisant

Publications (1)

Publication Number Publication Date
NO20084914L true NO20084914L (no) 2008-12-10

Family

ID=38667996

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084914A NO20084914L (no) 2006-05-09 2008-11-21 Parenteral formulering inneholdende proton pumpeinhibitor sterilisert i dens siste beholder ved ioniserende straling

Country Status (13)

Country Link
US (1) US20090111856A1 (fr)
EP (1) EP2018151A4 (fr)
JP (1) JP2009536195A (fr)
KR (1) KR20090024674A (fr)
CN (1) CN101442985A (fr)
AU (1) AU2007248949B2 (fr)
BR (1) BRPI0711048A2 (fr)
CA (1) CA2649946A1 (fr)
MX (1) MX2008014283A (fr)
NO (1) NO20084914L (fr)
NZ (1) NZ572007A (fr)
WO (1) WO2007129961A1 (fr)
ZA (1) ZA200808824B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE034356T2 (en) * 2012-05-09 2018-02-28 Icrom Spa Preparation of sterile medical brinzolamide
GB2513172A (en) * 2013-04-18 2014-10-22 Nupharm Lab Ltd Liquid dosage form and delivery system
CN103698430B (zh) * 2013-12-24 2015-01-21 江苏正大丰海制药有限公司 一种埃索美拉唑钠和注射用埃索美拉唑钠中杂质含量检测方法
CN105272965A (zh) * 2014-07-03 2016-01-27 上海汇伦生命科技有限公司 一种埃索美拉唑钠的纯化方法
GB201505347D0 (en) * 2015-03-27 2015-05-13 Salupont Consulting Ltd Sterilisation of s-nitrosothiols
US11793748B1 (en) * 2019-04-05 2023-10-24 Good Health, Llc Pharmaceutical compositions of aspirin for parenteral administration
US11666548B2 (en) * 2020-06-05 2023-06-06 Baxter International Inc. Parenteral nutrition formulation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
US4678809A (en) * 1985-02-01 1987-07-07 Michael Phillips Injectable fomulations of disulfiram for the treatment of alcoholism
DE4438360C2 (de) * 1994-10-27 1999-05-20 Schott Glas Vorfüllbare partikelarme, sterile Einmalspritze für die Injektion von Präparaten und Verfahren zu ihrer Herstellung
CA2291659A1 (fr) * 1997-06-04 1998-12-10 Debio Recherche Pharmaceutique S.A. Implants pour la liberation controlee de principes pharmaceutiquement actifs et procede pour leur fabrication
SE9903831D0 (sv) * 1999-10-22 1999-10-22 Astra Ab Formulation of substituted benzimidazoles
US7695736B2 (en) * 2001-04-03 2010-04-13 Pfizer Inc. Reconstitutable parenteral composition
JP2005523298A (ja) * 2002-03-15 2005-08-04 アルタナ　ファルマ　アクチエンゲゼルシャフト 非心臓性胸痛の治療のためのプロトンポンプ阻害剤の使用
BR0312802A (pt) * 2002-07-19 2005-04-19 Michael E Garst Pró-drogas de inibidores de bombas de próton
JP2006501936A (ja) * 2002-10-04 2006-01-19 エラン ファーマ インターナショナル，リミティド 固体ナノ粒子活性薬剤のガンマ線照射
PL375603A1 (en) * 2002-10-25 2005-12-12 Pfizer Products Inc. Depot formulations of arylheterocyclic active agents in the form of a suspension
DK1713476T3 (da) * 2003-11-05 2010-08-09 Lyka Labs Ltd Et nyt medicinindgiftssystem til protonnpumpehæmmere og proces dertil
JP2005200409A (ja) * 2003-12-17 2005-07-28 Takeda Chem Ind Ltd 注射剤
TW200526268A (en) * 2003-12-17 2005-08-16 Takeda Pharmaceutical Injectable composition

Also Published As

Publication number Publication date
US20090111856A1 (en) 2009-04-30
CN101442985A (zh) 2009-05-27
NZ572007A (en) 2010-12-24
AU2007248949A1 (en) 2007-11-15
AU2007248949B2 (en) 2010-04-08
ZA200808824B (en) 2009-11-25
BRPI0711048A2 (pt) 2011-08-23
WO2007129961A1 (fr) 2007-11-15
MX2008014283A (es) 2008-11-18
JP2009536195A (ja) 2009-10-08
KR20090024674A (ko) 2009-03-09
EP2018151A4 (fr) 2012-07-18
CA2649946A1 (fr) 2007-11-15
EP2018151A1 (fr) 2009-01-28

Similar Documents

Publication Publication Date Title
NO20084914L (no) Parenteral formulering inneholdende proton pumpeinhibitor sterilisert i dens siste beholder ved ioniserende straling
MX389597B (es) Inhibidores de cdk2/4/6 de piridopirimidinona.
MX2012006720A (es) Composicion farmceutica para el tratamiento de sindrome del ojo seco.
ECSP055640A (es) Composiciones de pirazol útiles como inhibidores de gsk-3
NO20090835L (no) Nye HIV-reverstranskriptaseinhibitorer
MX2009004475A (es) Composiciones que comprenden agentes acido labiles que inhiben la bomba de protones, por lo menos otro agente farmaceuticamente activo y metodos de uso de las misma.
BR112018000639A8 (pt) Sistema de cateter funcionalmente integrável
ECSP088747A (es) Pirazoles como inhibidores de la 11-beta-hsd1
BRPI0821004A8 (pt) Composto derivado de aminopirazol, composição farmacêutica que o contem e uso deste
NO20084435L (no) C-MET proteinkinaseinhibitorer
EA201490489A1 (ru) Пуриновые производные и их применение в качестве модуляторов толл-подобного рецептора 7
NO20100301L (no) Forbedrete brimonidinsammensetninger for behandling av erytem
CY1118017T1 (el) Υποβαλλοντας σε αγωγη την ανεπαρκεια και το ελλειμμα βιταμινης d με 25-υδροξυβιταμινη d2 και 25-υδροξυβιταμινη d3
BRPI0806713A8 (pt) Composições de tiacumicinas estáveis
CL2008002129A1 (es) Compuestos derivados de (1h-indazol-3-il)-amidas sustituidas, inhibidores de quinasa; composicion farmaceutica; procedimiento de preparacion; y uso del compuesto para el tratamiento del cancer.
EA201270666A1 (ru) Соединения и фармацевтические композиции для снижения уровня мочевой кислоты
EA201070597A1 (ru) Антибактериальные аналоги аминогликозида
MX386542B (es) Derivados de la 2,3-dihidro-isoindol-1-ona, como inhibidores de la btk quinasa y composiciones farmacéuticas que los incluyen.
UA118261C2 (uk) Хімічні сполуки
NI201100143A (es) Composición farmacéutica sólida que comprende amlodipina y losartan.
AR058780A1 (es) Imidazopirazinas como inhibidores de quinasas dependientes de ciclina
CY1111197T1 (el) Tριαζολες χρησιμες ως αναστολεις πρετεϊνικων κινασων
MX380878B (es) Composiciones de alta penetracion y sus aplicaciones.
CL2015002608A1 (es) Compuesto de amino-pirazol y usos medicinales relacionados.
CL2008002999A1 (es) Uso de una composicion farmeceutica que comprende trns-clominefo para preparar un medicamenteo util en el ratamiento de recuccion de los niveles de glucosa en ayunas en un varon.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application